Pediatric Department A, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
The Jesse Z. and Lea Shafer Institute of Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Pediatr Diabetes. 2018 Nov;19(7):1147-1155. doi: 10.1111/pedi.12694. Epub 2018 Jun 13.
BACKGROUND/AIMS: Childhood obesity and associated metabolic comorbidities is a major global health concern. Metabolically healthy obesity (MHO) may represent a subgroup of individuals in which excessive body fat accumulation does not lead to adverse metabolic effects. We aimed to determine the prevalence of MHO among obese Israeli children and adolescents and to find predictors for metabolically unhealthy obesity (MUO).
In a retrospective study, demographic, anthropometric, lifestyle, and cardiometabolic data were retrieved from medical records of patients with a body mass index (BMI) >95th percentile aged 6 to 17.6 years, attending a tertiary pediatric obesity clinic between 2008 and 2015, with at least 1 year of follow-up. Participants were dichotomized as either MHO or MUO based on cardiometabolic risk factor clustering (blood pressure, serum lipids, and glucose). Multivariable logistic regression was used to determine predictors of MUO.
Of the 230 children (median age 9.9 years) fulfilling study criteria, 48 (20.9%) were classified as MHO. Occurrence of MUO was associated with male gender, Arabic ethnicity, higher BMI-SD score, higher tri-ponderal mass index (TMI), and higher insulin resistance (IR) (presence of acanthosis nigricans and a higher level of homeostasis model assessment-IR [HOMA-IR]). Male gender (odds ratio [OR] 2.27, P = .033), presence of acanthosis nigricans at baseline (OR 2.35, P = .035), and a greater increase in BMI-SDS during follow-up (OR 2.82, P = .05) were the best predictors of MUO.
The MHO phenotype was present in only 20.9% of obese Israeli children. MUO was significantly associated with male gender, with presence of acanthosis nigricans, and with a greater increase in BMI-SDS during follow-up.
背景/目的:儿童肥胖症及相关代谢合并症是一个重大的全球健康问题。代谢健康肥胖症(MHO)可能代表了一个亚组人群,其中过多的体脂积累不会导致不良的代谢影响。我们旨在确定以色列肥胖儿童和青少年中 MHO 的患病率,并找到代谢不健康肥胖症(MUO)的预测因素。
在一项回顾性研究中,我们从 2008 年至 2015 年期间在一家三级儿科肥胖诊所就诊的年龄在 6 至 17.6 岁之间、BMI 超过第 95 百分位的患者的病历中检索了人口统计学、人体测量学、生活方式和心血管代谢数据,这些患者至少随访了 1 年。根据心血管代谢危险因素聚类(血压、血清脂质和血糖),将参与者分为 MHO 或 MUO。多变量逻辑回归用于确定 MUO 的预测因素。
符合研究标准的 230 名儿童(中位年龄 9.9 岁)中,有 48 名(20.9%)被归类为 MHO。MUO 的发生与男性性别、阿拉伯裔、更高的 BMI-SD 评分、更高的三指数质量指数(TMI)和更高的胰岛素抵抗(IR)(存在黑棘皮病和更高的稳态模型评估-IR [HOMA-IR])相关。男性性别(比值比[OR] 2.27,P=.033)、基线时存在黑棘皮病(OR 2.35,P=.035)和随访期间 BMI-SDS 增加更多(OR 2.82,P=.05)是 MUO 的最佳预测因素。
在以色列肥胖儿童中,MHO 表型仅占 20.9%。MUO 与男性性别显著相关,与黑棘皮病的存在以及随访期间 BMI-SDS 的更大增加相关。